Non-alcoholic fatty liver disease in women with PCOS

Clinical trials for Non-alcoholic fatty liver disease in women with PCOS explained in plain language.

Never miss a new study

Get alerted when new Non-alcoholic fatty liver disease in women with PCOS trials appear

Sign up with your email to follow new studies for Non-alcoholic fatty liver disease in women with PCOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

New drug hope for fatty liver in PCOS women?

Disease control Stopped early

This study tested a drug called saroglitazar in women with polycystic ovary syndrome (PCOS) who also have nonalcoholic fatty liver disease (NAFLD). The goal was to see if the drug could safely reduce liver fat over 24 weeks compared to a placebo. The trial was planned for 60 wome…

Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH PCOS

Phase 2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC

Non-alcoholic fatty liver disease in women with PCOS

Get alerted when new Non-alcoholic fatty liver disease in women with PCOS trials appear

New drug hope for fatty liver in PCOS women?